Diffusion of minimally invasive therapy in Europe
article
This paper considers the diffusion of the 10 cases presented in this issue. Most of the cases have diffused relatively slowly. This slow diffusion can be explained by a number of factors, including budgetary restraints, financial incentives, physician conservatism, and lack of appropriate training. A consistent thread in the cases is the argument that evidence of effectiveness is not convincing. The article considers whether further diffusion of each innovation can be justified from existing evidence. This information is important for policy purposes. Policies might be developed to encourage or to discourage any potentially important innovation.
Topics
diffusionhealth policyincentivesminimally invasive therapyextracorporeal lithotripsyhealth care policyhumanlaparoscopylaser surgerymedical technologyshort surveysurgical techniqueAngioplasty, Transluminal, Percutaneous CoronaryCoronary Artery BypassCost-Benefit AnalysisDiffusion of InnovationEndoscopyEuropeHealth PolicyLaparoscopyLaser SurgeryLithotripsySurgical Procedures, OperativeTechnology Assessment, BiomedicalTherapeutics
TNO Identifier
232213
ISSN
01688510
Source
Health Policy, 23(1-2), pp. 125-133.
Pages
125-133
Files
To receive the publication files, please send an e-mail request to TNO Repository.